Insider Buy/Sell Ratio — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
By Sector
Healthcare
Buys44
Sells464
Buy $$3.15M
Sell $$1.25B
Ratio1:397.29
% Change vs. Prior
Ratio -92.6%Value +27.4%
Technology
Buys25
Sells644
Buy $$8.54M
Sell $$466.58M
Ratio1:54.61
% Change vs. Prior
Ratio -9.1%Value -58.1%
Basic Materials
Buys13
Sells16
Buy $$5.08M
Sell $$204.68M
Ratio1:40.31
% Change vs. Prior
Ratio -72.2%Value +15195.1%
Consumer Cyclical
Buys16
Sells102
Buy $$2.42M
Sell $$192.12M
Ratio1:79.37
% Change vs. Prior
Ratio +8.7%Value -3.4%
Financial Services
Buys49
Sells132
Buy $$3.69M
Sell $$165.28M
Ratio1:44.78
% Change vs. Prior
Ratio -61.7%Value +44.5%
Energy
Buys6
Sells18
Buy $$171.07K
Sell $$57.64M
Ratio1:336.92
% Change vs. Prior
Ratio -43.9%Value -91.3%
Consumer Defensive
Buys7
Sells48
Buy $$726.96K
Sell $$29.24M
Ratio1:40.22
% Change vs. Prior
Ratio +278.8%Value -88.9%
Industrials
Buys12
Sells79
Buy $$707.04K
Sell $$29.22M
Ratio1:41.32
% Change vs. Prior
Ratio +32.6%Value -79.5%
Communication Services
Buys5
Sells74
Buy $$2.24M
Sell $$17.64M
Ratio1:7.87
% Change vs. Prior
Ratio -97.5%Value -49.4%
Utilities
Buys4
Sells9
Buy $$1.10M
Sell $$11.97M
Ratio1:10.89
% Change vs. Prior
Ratio -85.3%Value +33.1%
Real Estate
Buys37
Sells20
Buy $$871.14K
Sell $$12.18M
Ratio1:13.98
% Change vs. Prior
Ratio +225.4%Value -20.3%
By Industry
Biotechnology
Buys38
Sells339
Buy $$2.76M
Sell $$883.41M
Ratio1:319.97
% Change vs. Prior
Ratio -91.4%Value +15.3%
Chemicals - Specialty
Buys7
Sells8
Buy $$4.55M
Sell $$199.27M
Ratio1:43.75
Semiconductors
Buys2
Sells100
Buy $$152.34K
Sell $$149.21M
Ratio1:979.45
% Change vs. Prior
Ratio +502.6%Value -68.1%
Medical - Healthcare Information Services
Buys0
Sells64
Buy $$0.00
Sell $$148.43M
RatioAll Sells
% Change vs. Prior
Ratio NaN%Value +40.0%
Software - Infrastructure
Buys0
Sells272
Buy $$0.00
Sell $$137.03M
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value -37.9%
Specialty Retail
Buys5
Sells46
Buy $$2.06M
Sell $$97.31M
Ratio1:47.31
% Change vs. Prior
Ratio +443.6%Value +178.0%
Software - Application
Buys13
Sells67
Buy $$3.30M
Sell $$91.77M
Ratio1:27.83
% Change vs. Prior
Ratio -41.0%Value -72.7%
Financial - Credit Services
Buys0
Sells52
Buy $$0.00
Sell $$77.18M
RatioAll Sells
Medical - Care Facilities
Buys0
Sells9
Buy $$0.00
Sell $$76.50M
RatioAll Sells
Medical - Diagnostics & Research
Buys1
Sells13
Buy $$199.09K
Sell $$59.59M
Ratio1:299.30
Medical - Healthcare Plans
Buys0
Sells9
Buy $$0.00
Sell $$55.92M
RatioAll Sells
% Change vs. Prior
Ratio NaN%Value +15.7%
Oil & Gas Refining & Marketing
Buys0
Sells6
Buy $$0.00
Sell $$50.31M
RatioAll Sells
Travel Services
Buys0
Sells10
Buy $$0.00
Sell $$49.57M
RatioAll Sells
Computer Hardware
Buys0
Sells60
Buy $$0.00
Sell $$35.64M
RatioAll Sells
Insurance - Specialty
Buys0
Sells6
Buy $$0.00
Sell $$30.19M
RatioAll Sells
Transactions (1903)
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
52,935
Price
$151.16
Total Value
$8.00M
Shares Held After
1,881,336
% of Holdings
2.7%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
64,037
Price
$150.49
Total Value
$9.64M
Shares Held After
1,934,271
% of Holdings
3.2%
NERDWALLET, INC. (NRDS)
Topline Capital Management, LLC — See Explanation in Footnotes
Shares
919,153
Price
$8.95
Total Value
$8.23M
Shares Held After
4,331,992
% of Holdings
17.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,729
Price
$118.66
Total Value
$205.16K
Shares Held After
472,267
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,069
Price
$117.85
Total Value
$361.68K
Shares Held After
473,996
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,701
Price
$117.09
Total Value
$199.17K
Shares Held After
477,065
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
952
Price
$115.69
Total Value
$110.14K
Shares Held After
478,766
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,896
Price
$114.94
Total Value
$447.81K
Shares Held After
479,718
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,083
Price
$113.97
Total Value
$237.40K
Shares Held After
483,614
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
78
Price
$112.49
Total Value
$8.77K
Shares Held After
485,697
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,442
Price
$111.51
Total Value
$160.80K
Shares Held After
485,775
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,579
Price
$110.49
Total Value
$174.46K
Shares Held After
487,217
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,562
Price
$109.79
Total Value
$500.86K
Shares Held After
488,796
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
32,402
Price
$108.14
Total Value
$3.50M
Shares Held After
493,358
% of Holdings
6.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,958
Price
$107.57
Total Value
$425.76K
Shares Held After
525,760
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,390
Price
$118.66
Total Value
$1.47M
Shares Held After
2,451,924
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
22,046
Price
$117.85
Total Value
$2.60M
Shares Held After
2,464,314
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,181
Price
$117.09
Total Value
$1.43M
Shares Held After
2,486,360
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
6,821
Price
$115.69
Total Value
$789.12K
Shares Held After
2,498,541
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
27,951
Price
$114.94
Total Value
$3.21M
Shares Held After
2,505,362
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,913
Price
$113.97
Total Value
$1.70M
Shares Held After
2,533,313
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
555
Price
$112.49
Total Value
$62.43K
Shares Held After
2,548,226
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,366
Price
$111.51
Total Value
$1.16M
Shares Held After
2,548,781
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,277
Price
$110.49
Total Value
$1.25M
Shares Held After
2,559,147
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
32,624
Price
$109.79
Total Value
$3.58M
Shares Held After
2,570,424
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
231,007
Price
$108.14
Total Value
$24.98M
Shares Held After
2,603,048
% of Holdings
8.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
28,296
Price
$107.57
Total Value
$3.04M
Shares Held After
2,834,055
% of Holdings
1.0%
Beta Bionics, Inc. (BBNX)
Feider Stephen — Chief Financial Officer
Shares
5,104
Price
$17.05
Total Value
$87.01K
Shares Held After
165,931
% of Holdings
3.0%
Essent Group Ltd. (ESNT)
WEINSTOCK DAVID B — SVP and CFO
Shares
5,500
Price
$63.51
Total Value
$349.31K
Shares Held After
35,494
% of Holdings
13.4%
GRIFFON CORP (GFF)
MEHMEL ROBERT F — President and COO
Shares
4
Price
$97.50
Total Value
$390.00
Shares Held After
790,066
% of Holdings
0.0%
GRIFFON CORP (GFF)
MEHMEL ROBERT F — President and COO
Shares
52
Price
$96.14
Total Value
$5.00K
Shares Held After
790,070
% of Holdings
0.0%
GRIFFON CORP (GFF)
MEHMEL ROBERT F — President and COO
Shares
230
Price
$95.52
Total Value
$21.97K
Shares Held After
790,122
% of Holdings
0.0%
PARK OHIO HOLDINGS CORP (PKOH)
VILSACK ROBERT D — Secretary & CLO
Shares
1,000
Price
$38.65
Total Value
$38.65K
Shares Held After
186,539
% of Holdings
0.5%
PARK OHIO HOLDINGS CORP (PKOH)
VILSACK ROBERT D — Secretary & CLO
Shares
932
Price
$38.50
Total Value
$35.88K
Shares Held After
187,539
% of Holdings
0.5%
PARK OHIO HOLDINGS CORP (PKOH)
VILSACK ROBERT D — Secretary & CLO
Shares
3,100
Price
$38.40
Total Value
$119.04K
Shares Held After
188,471
% of Holdings
1.6%
PARK OHIO HOLDINGS CORP (PKOH)
VILSACK ROBERT D — Secretary & CLO
Shares
605
Price
$38.39
Total Value
$23.23K
Shares Held After
191,571
% of Holdings
0.3%
NEUROCRINE BIOSCIENCES INC (NBIX)
Lippoldt Darin — Chief Legal Officer
Shares
200
Price
$169.56
Total Value
$33.91K
Shares Held After
54,729
% of Holdings
0.4%
PARK OHIO HOLDINGS CORP (PKOH)
VILSACK ROBERT D — Secretary & CLO
Shares
767
Price
$38.35
Total Value
$29.41K
Shares Held After
192,176
% of Holdings
0.4%
NERDWALLET, INC. (NRDS)
Topline Capital Partners, LP — 10% Owner
Shares
919,153
Price
$8.95
Total Value
$8.23M
Shares Held After
4,331,992
% of Holdings
17.5%
WIDEPOINT CORP (WYY)
GEORGE ROBERT J — Chief Financial Officer
Shares
3,962
Price
$19.35
Total Value
$76.66K
Shares Held After
36,724
% of Holdings
9.7%
WIDEPOINT CORP (WYY)
GEORGE ROBERT J — Chief Financial Officer
Shares
11,901
Price
$17.78
Total Value
$211.60K
Shares Held After
40,686
% of Holdings
22.6%
Afya Ltd (AFYA)
Basolli Gomiero Mirella — Vice President
Shares
10,000
Price
$14.80
Total Value
$148.00K
Shares Held After
34,530
% of Holdings
22.5%
LifeStance Health Group, Inc. (LFST)
Bessler Robert — Director
Shares
447,169
Price
$10.13
Total Value
$4.53M
Shares Held After
656,560
% of Holdings
40.5%
LifeStance Health Group, Inc. (LFST)
Bessler Robert — Director
Shares
447,168
Price
$10.13
Total Value
$4.53M
Shares Held After
539,763
% of Holdings
45.3%
Afya Ltd (AFYA)
Junior Lelio de Souza — Vice President
Shares
41,541
Price
$15.00
Total Value
$623.12K
Shares Held After
36,204
% of Holdings
53.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
596
Price
$482.50
Total Value
$287.57K
Shares Held After
15,337
% of Holdings
3.7%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
2,500
Price
$44.90
Total Value
$112.25K
Shares Held After
886
% of Holdings
73.8%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
232
Price
$44.90
Total Value
$10.42K
Shares Held After
886
% of Holdings
20.8%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
5,000
Price
$45.00
Total Value
$225.00K
Shares Held After
75,753
% of Holdings
6.2%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
5,000
Price
$45.00
Total Value
$225.00K
Shares Held After
75,753
% of Holdings
6.2%
Showing 301–350 of 1903 transactions (page 7 of 39)